These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30035347)

  • 41. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
    Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
    Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
    Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progression of precancerous lesions to oral cancer: results based on the Taiwan National Health Insurance Database.
    Lian IeB; Tseng YT; Su CC; Tsai KY
    Oral Oncol; 2013 May; 49(5):427-30. PubMed ID: 23273345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo autofluorescence spectroscopy of oral premalignant and malignant lesions: distortion of fluorescence intensity by submucous fibrosis.
    Tsai T; Chen HM; Wang CY; Tsai JC; Chen CT; Chiang CP
    Lasers Surg Med; 2003; 33(1):40-7. PubMed ID: 12866120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.
    Chen J; Li W; Liu B; Xie X
    BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokeratin expression in oral submucous fibrosis--an immunohistochemical study.
    Ranganathan K; Kavitha R; Sawant SS; Vaidya MM
    J Oral Pathol Med; 2006 Jan; 35(1):25-32. PubMed ID: 16393250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mast cell density and angiogenesis in oral dysplastic epithelium and low- and high-grade oral squamous cell carcinoma.
    Mohtasham N; Babakoohi S; Salehinejad J; Montaser-Kouhsari L; Shakeri MT; Shojaee S; Sistani NS; Firooz A
    Acta Odontol Scand; 2010 Sep; 68(5):300-4. PubMed ID: 20586672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of M1 (CD11c) and M2 (CD163) interplay in the pathogenesis of oral submucous fibrosis and its malignant transformation: An immunohistochemical analysis.
    Parekh NM; Desai RS; Bansal SP; Shirsat PM; Prasad PS
    Cytokine; 2024 Nov; 183():156742. PubMed ID: 39217916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
    Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
    Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma.
    Kim EK; Moon S; Kim DK; Zhang X; Kim J
    PLoS One; 2018; 13(1):e0188847. PubMed ID: 29360827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets.
    Qin X; Ning Y; Zhou L; Zhu Y
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The phosphorylation of survivin Thr34 by p34cdc2 in carcinogenesis of oral submucous fibrosis.
    Zhou S; Li L; Jian X; Ou X; Jiang H; Yao Z; Xu C; Peng J
    Oncol Rep; 2008 Nov; 20(5):1085-91. PubMed ID: 18949405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis.
    Pant I; Rao SG; Kondaiah P
    Sci Rep; 2016 Oct; 6():34314. PubMed ID: 27708346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis.
    Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B
    J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
    Su TR; Liao YW; Hsieh PL; Tsai LL; Fang CY; Lin T; Lee YH; Harn HJ; Yu CC
    Environ Toxicol; 2018 Jun; 33(6):686-694. PubMed ID: 29665273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
    Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
    J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
    Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
    Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
    Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
    Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis.
    Yu CC; Yu CH; Chang YC
    Sci Rep; 2016 Nov; 6():37004. PubMed ID: 27845370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
    Chen PN; Lin CW; Yang SF; Chang YC
    J Cell Mol Med; 2021 Oct; 25(20):9814-9825. PubMed ID: 34528373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.